Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmally, formally Pharmally International Holding Company Limited, was a Taiwan-listed pharmaceutical manufacturer focused on large-volume injections and pharmaceutical raw materials. The company operated primarily through manufacturing assets in China, including Luan Worldbest Pharmaceutical Company, and marketed infusion products and active pharmaceutical ingredients in Asian markets. Public disclosures describe its business as production and sale of injections, bulk drugs, and related pharmaceutical products rather than discovery-stage biotech R&D. Available sources indicate the company is no longer active and has been identified as closed/delisted. It does not appear to have a disclosed innovative therapeutic pipeline in the biotech sense; instead, it was a commercial pharmaceutical manufacturing business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmally.